Adipose tissue-derived mesenchymal stromal cells for clinical application: An efficient isolation approach
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Current Research in Translational Medicine
- Vol. 67 (1) , 20-27
Abstract
No abstract availableKeywords
Funding Information
- Italian Ministry of Health
This publication has 31 references indexed in Scilit:
- Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical applicationStem Cell Research & Therapy, 2013
- Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT)Cytotherapy, 2013
- Mesenchymal stromal cells: misconceptions and evolving conceptsCytotherapy, 2013
- Induction Therapy With Autologous Mesenchymal Stem Cells in Living-Related Kidney TransplantsJAMA, 2012
- Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept studyThe Lancet Neurology, 2012
- Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's diseaseGut, 2011
- Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II studyThe Lancet, 2008
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999
- Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progenyBlood, 1980